Time Scale Financial, Inc. Verastem, Inc. Transaction History

Time Scale Financial, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$0.39 - $0.71 $694 - $1,263	-1,780 Reduced 99.33%	12 $0
Q3 2022 Oct 05, 2022	SELL	$0.92 - $11.16 $80 - $982	-88 Reduced 4.68%	1,792 $2,000
Q3 2020 Oct 07, 2020	BUY	$1.11 - $1.68 $1,975 - $2,990	1,780 Added 1780.0%	1,880 $2,000
Q2 2019 Jul 31, 2019	BUY	$1.25 - $3.14 $125 - $314	100 New	100 $0

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Time Scale Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Time Scale Financial, Inc. with notifications on news.